Ensign Peak Advisors, Inc
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1454984
SALT LAKE CITY, UT
Position in ARWR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,340,478
-$1,366,408 QoQ
Shares Held
28,714
-51.4% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#188
of 497 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names. ARWR ranks #62 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in ARWR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,340,478 | 28,714 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,706,886 | 59,121 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,549,277 | 23,336 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $744,673 | 21,591 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $766,947 | 48,541 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $618,412 | 48,541 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $912,570 | 48,541 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $940,239 | 48,541 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,261,580 | 48,541 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,388,272 | 48,541 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,560,294 | 50,990 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,370,101 | 50,990 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,818,303 | 50,990 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,295,146 | 50,990 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,238,337 | 178,460 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,288,330 | 160,010 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,848,628 | 137,706 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,529,627 | 33,260 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,283,040 | 34,435 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $5,212,905 | 83,500 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,372,770 | 101,096 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $7,059,760 | 106,466 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $8,484,189 | 110,572 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,434,602 | 126,210 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,870,255 | 89,610 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $3,221,578 | 111,977 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||